Chun Chou, Ph.D., Postdoctoral FellowMemorial Sloan Kettering Cancer Center

The CRI postdoctoral fellowship offers generous support for my research to understand unexplored cancer immunosurveillance mechanisms.
Area of Research: Breast Cancer

While current immunotherapies work relatively well for patients whose tumors are already infiltrated by “killer” T cells characterized by the CD8 marker. However, a substantial fraction of patients lack these “killer” T cells in their tumors, which may result in these immunotherapies being ineffective. Recently, a new group of tumor-infiltrating immune cells—innate-like T cells (ILTCs)—were identified in breast tumors. These ILTCs are in close contact with tumor cells and can readily kill them. To evaluate the potential clinical value of these ILTCs, Dr. Chun Chou is investigating how they develop and what signals enable their robust anti-tumor activity. As a result, Dr. Chou’s work has the potential to not only broaden our understanding of how the immune system as a whole interacts with and surveys tumors, but also pave the way for novel immunotherapy strategies that harness ILTCs.

Projects and Grants

Origin and regulation of innate-like T cell responses in cancer

Memorial Sloan Kettering Cancer Center | Breast Cancer | 2018 | Ming O. Li, Ph.D.

Let's spread the word about Immunotherapy! Click to share this page with your community.

*Immunotherapy results may vary from patient to patient.